BioAge Labs, Inc.
BIOA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709941
No open-market purchases or sales by BioAge Labs, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in BioAge Labs, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +58 vs. Q2 2024
- Shares held
- 20.7M
- +20.7M vs. Q2 2024
- Total value
- $430.8M
- +$430.8M vs. Q2 2024
- New holders
- 58
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BIOA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $924.6M |
| Q1 2026 | 144 | $599.2M |
| Q4 2025 | 114 | $314.1M |
| Q3 2025 | 94 | $125.0M |
| Q2 2025 | 83 | $85.6M |
| Q1 2025 | 67 | $76.2M |
| Q4 2024 | 65 | $113.7M |
| Q3 2024 | 58 | $430.8M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding BioAge Labs, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 33 | $686 | 0.00% | +33 | New |
| Tower Research Capital LLC (TRC) | 37 | $770 | 0.00% | +37 | New |
| Bank of America Corp | 525 | $10.9K | 0.00% | +525 | New |
| Parallel Advisors, LLC | 731 | $15.2K | 0.00% | +731 | New |
| Morgan Stanley | 2,309 | $48.0K | 0.00% | +2,309 | New |
| Point72 Asset Management, L.P. | 2,700 | $56.2K | 0.00% | +2,700 | New |
| Aster Capital Management (DIFC) Ltd | 6,988 | $145.3K | 0.03% | +6,988 | New |
| HRT Financial LP | 9,813 | $204.0K | 0.00% | +9,813 | New |
| Two Sigma Investments, LP | 11,500 | $239.2K | 0.00% | +11,500 | New |
| Barclays PLC | 11,900 | $247.5K | 0.00% | +11,900 | New |
| Landscape Capital Management, L.L.C. | 12,643 | $263.0K | 0.03% | +12,643 | New |
| Valor Management LLC | 13,105 | $272.6K | 0.06% | +13,105 | New |
| Teacher Retirement System of Texas | 20,000 | $416.0K | 0.00% | +20,000 | New |
| Maven Securities LTD | 25,000 | $520.0K | 0.06% | +25,000 | New |
| Manufacturers Life Insurance Company, The | 26,677 | $554.9K | 0.00% | +26,677 | New |
| Ghisallo Capital Management LLC | 30,000 | $624.0K | 0.03% | +30,000 | New |
| Kodai Capital Management LP | 30,000 | $624.0K | 0.01% | +30,000 | New |
| Squarepoint Ops LLC | 36,314 | $755.3K | 0.00% | +36,314 | New |
| Vanguard Group Inc | 40,000 | $832.0K | 0.00% | +40,000 | New |
| Norges Bank | 40,000 | $832.0K | 0.00% | +40,000 | New |
| Jane Street Group, LLC | 43,073 | $895.9K | 0.00% | +43,073 | New |
| Platinum Investment Management Ltd | 50,000 | $1.04M | 0.05% | +50,000 | New |
| Point72 (DIFC) Ltd | 55,080 | $1.15M | 0.09% | +55,080 | New |
| TD Asset Management Inc | 59,678 | $1.25M | 0.00% | +59,678 | New |
| Walleye Capital LLC | 76,875 | $1.60M | 0.02% | +76,875 | New |
| Monashee Investment Management LLC | 95,000 | $1.98M | 0.21% | +95,000 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 100,000 | $2.08M | 0.04% | +100,000 | New |
| Silverarc Capital Management, LLC | 100,000 | $2.08M | 0.47% | +100,000 | New |
| Goldman Sachs Group Inc | 108,616 | $2.26M | 0.00% | +108,616 | New |
| Howard Hughes Medical Institute | 113,765 | $2.37M | 0.38% | +113,765 | New |
| Balyasny Asset Management LLC | 120,000 | $2.50M | 0.01% | +120,000 | New |
| Woodline Partners LP | 124,950 | $2.60M | 0.02% | +124,950 | New |
| Zimmer Partners, LP | 125,000 | $2.60M | 0.05% | +125,000 | New |
| Alyeska Investment Group, L.P. | 150,000 | $3.12M | 0.02% | +150,000 | New |
| Healthcare of Ontario Pension Plan Trust Fund | 150,000 | $3.12M | 0.01% | +150,000 | New |
| Millennium Management LLC | 166,022 | $3.45M | 0.00% | +166,022 | New |
| Marshall Wace, LLP | 200,000 | $4.16M | 0.01% | +200,000 | New |
| JPMorgan Chase & Co | 200,000 | $4.16M | 0.00% | +200,000 | New |
| FIL Ltd | 200,000 | $4.16M | 0.00% | +200,000 | New |
| Citadel Advisors LLC | 213,718 | $4.45M | 0.00% | +213,718 | New |
| Emerald Mutual Fund Advisers Trust | 229,431 | $4.77M | 0.25% | +229,431 | New |
| Wasatch Advisors Inc | 254,907 | $5.30M | 0.03% | +254,907 | New |
| Comprehensive Financial Management LLC | 271,842 | $5.65M | 0.16% | +271,842 | New |
| Emerald Advisers, LLC | 281,317 | $5.85M | 0.23% | +281,317 | New |
| Siren, L.L.C. | 300,000 | $6.24M | 0.31% | +300,000 | New |
| Brown Advisory Inc | 334,915 | $6.97M | 0.01% | +334,915 | New |
| Redpoint Management, LLC | 383,255 | $7.97M | 1.49% | +383,255 | New |
| Price T Rowe Associates Inc | 449,837 | $9.36M | 0.00% | +449,837 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 527,647 | $11.0M | 6.51% | +527,647 | New |
| RTW Investments, LP | 786,353 | $16.4M | 0.24% | +786,353 | New |
| Alliancebernstein L.P. | 994,315 | $20.7M | 0.01% | +994,315 | New |
| Sands Capital Ventures, LLC | 1,086,353 | $22.6M | 6.35% | +1,086,353 | New |
| OrbiMed Advisors LLC | 1,423,470 | $29.6M | 0.54% | +1,423,470 | New |
| Suvretta Capital Management, LLC | 1,455,000 | $30.3M | 1.09% | +1,455,000 | New |
| Cormorant Asset Management, LP | 1,629,529 | $33.9M | 1.80% | +1,629,529 | New |
| Ra Capital Management, L.P. | 2,210,589 | $46.0M | 0.53% | +2,210,589 | New |
| Sofinnova Investments, Inc. | 2,304,901 | $47.9M | 3.97% | +2,304,901 | New |
| AH Capital Management, L.L.C. | 3,013,975 | $62.7M | 5.51% | +3,013,975 | New |